skip to main content
Tipo de recurso Mostra resultados com: Mostra resultados com: Índice

Nicotinamide Riboside and Metformin Ameliorate Mitophagy Defect in Induced Pluripotent Stem Cell-Derived Astrocytes With POLG Mutations

Chen, Anbin ; Kristiansen, Cecilie Katrin ; Hong, Yu ; Kianian, Atefeh ; Fang, Evandro Fei ; Sullivan, Gareth John ; Wang, Jian ; Li, Xingang ; Bindoff, Laurence A. ; Liang, Kristina Xiao

Frontiers in cell and developmental biology, 2021-09, Vol.9, p.737304-737304 [Periódico revisado por pares]

Frontiers Media S.A

Texto completo disponível

Citações Citado por
  • Título:
    Nicotinamide Riboside and Metformin Ameliorate Mitophagy Defect in Induced Pluripotent Stem Cell-Derived Astrocytes With POLG Mutations
  • Autor: Chen, Anbin ; Kristiansen, Cecilie Katrin ; Hong, Yu ; Kianian, Atefeh ; Fang, Evandro Fei ; Sullivan, Gareth John ; Wang, Jian ; Li, Xingang ; Bindoff, Laurence A. ; Liang, Kristina Xiao
  • Assuntos: astrocytes ; Cell and Developmental Biology ; IPSC (induced pluripotent stem cells) ; metformin ; mitophagy ; nicotinamide riboside (NR) ; POLG
  • É parte de: Frontiers in cell and developmental biology, 2021-09, Vol.9, p.737304-737304
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
    NFR/262613
    Edited by: Andreas Hermann, University Hospital of Rostock, Germany
    Reviewed by: Anne Grünewald, University of Luxembourg, Luxembourg; Nataliia Naumova, University of Padua, Italy
    These authors have contributed equally to this work and share last authorship
    This article was submitted to Stem Cell Research, a section of the journal Frontiers in Cell and Developmental Biology
  • Descrição: Mitophagy specifically recognizes and removes damaged or superfluous mitochondria to maintain mitochondrial homeostasis and proper neuronal function. Defective mitophagy and the resulting accumulation of damaged mitochondria occur in several neurodegenerative diseases. Previously, we showed mitochondrial dysfunction in astrocytes with POLG mutations, and here, we examined how POLG mutations affect mitophagy in astrocytes and how this can be ameliorated pharmacologically. Using induced pluripotent stem cell (iPSC)-derived astrocytes carrying POLG mutations, we found downregulation of mitophagy/autophagy-related genes using RNA sequencing-based KEGG metabolic pathway analysis. We confirmed a deficit in mitochondrial autophagosome formation under exogenous stress conditions and downregulation of the mitophagy receptor p62, reduced lipidation of LC3B-II, and decreased expression of lysosome protein lysosomal-associated membrane protein 2A (LAMP2A). These changes were regulated by the PINK1/Parkin pathway and AKT/mTOR/AMPK/ULK1 signaling pathways. Importantly, we found that double treatment with nicotinamide riboside (NR) and metformin rescued mitophagy defects and mitochondrial dysfunction in POLG-mutant astrocytes. Our findings reveal that impaired mitophagy is involved in the observed mitochondrial dysfunction caused by POLG mutations in astrocytes, potentially contributing to the phenotype in POLG-related diseases. This study also demonstrates the therapeutic potential of NR and metformin in these incurable mitochondrial diseases.
  • Editor: Frontiers Media S.A
  • Idioma: Inglês;Norueguês

Buscando em bases de dados remotas. Favor aguardar.